SISTEMA SEROTONÉRGICO Y SU IMPLICACION FARMACOLÓGICA EN PATOLOGÍAS CARDIOVASCULARES
Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (10)
2017
-
The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
Oncotarget, Vol. 8, Núm. 16, pp. 26027-26040
2014
-
Characterization of human mesenchymal stem cells from Ewing sarcoma patients. Pathogenetic implications
PLoS ONE, Vol. 9, Núm. 2
-
Innovative therapies in ewing sarcoma
Advances in Anatomic Pathology, Vol. 21, Núm. 1, pp. 44-62
2013
-
The calcium-sensing receptor is silenced by genetic and epigenetic mechanisms in unfavorable neuroblastomas and its reactivation induces ERK1/2-dependent apoptosis
Carcinogenesis, Vol. 34, Núm. 2, pp. 268-276
-
WEE1 accumulation and deregulation of S-phase proteins mediate MLN4924 potent inhibitory effect on Ewing sarcoma cells
Oncogene, Vol. 32, Núm. 11, pp. 1441-1451
2012
-
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma
Oncogene, Vol. 31, Núm. 10, pp. 1287-1298
2011
-
Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain
APMIS, Vol. 119, Núm. 3, pp. 204-215
2009
-
Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target
British Journal of Cancer, Vol. 101, Núm. 1, pp. 80-90
2008
-
A pivotal role for heat shock protein 90 in Ewing sarcoma resistance to anti-insulin-like growth factor 1 receptor treatment: In vitro and in vivo study
Cancer Research, Vol. 68, Núm. 15, pp. 6260-6270
2006
-
Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor
Clinical Cancer Research, Vol. 12, Núm. 11 I, pp. 3532-3540